Skip to main content

Advertisement

Log in

In Vitro Studies Indicate Intravenous Lipid Emulsion Acts as Lipid Sink in Verapamil Poisoning

  • Original Article
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Intravenous lipid emulsion (ILE), a component of parenteral nutrition, consists of a fat emulsion of soy bean oil, egg phospholipids, and glycerin. Case reports suggest that ILE may reverse hypotension caused by acute poisoning with lipophilic drugs such as verapamil, but the mechanism remains unclear. The methods used are the following: (1) measurement of ILE concentration in serum samples from a patient with verapamil poisoning treated with ILE, (2) measurement of free verapamil concentrations in human serum mixed in vitro with increasing concentrations of ILE, and (3) measurement of murine ventricular cardiomyocyte l-type Ca2+ currents, intracellular Ca2+, and contractility in response to verapamil and/or ILE. Maximum patient serum ILE concentration after infusion of 1 L ILE over 1 h was approximately 1.6 vol%. In vitro GC/MS verapamil assays showed that addition of ILE (0.03–5.0 vol%) dose-dependently decreased the free verapamil concentration in human serum. In voltage-clamped myocytes, adding ILE to Tyrode’s solution containing 5 μM verapamil recovered l-type Ca2+ currents (ICa). Recovery was concentration dependent, with significant ICa recovery at ILE concentrations as low as 0.03 vol%. ILE had no effect on ICa in the absence of verapamil. In field-stimulated intact ventricular myocytes exposed to verapamil, adding ILE (0.5 %) resulted in a rapid and nearly complete recovery of myocyte contractility and intracellular Ca2+. Our in vitro studies indicate that ILE acts as a lipid sink that rapidly reverses impaired cardiomyocyte contractility in the continued presence of verapamil.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mowry JB, Spyker DA, Cantilena Jr LR, McMillan N, Ford M. 2013 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol. 2014;52(10):1032–283.

    Article  Google Scholar 

  2. Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol. 2010;48(8):806–12.

    Article  CAS  Google Scholar 

  3. Kline JA, Tomaszewski CA, Schroeder JD, Raymond RM. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther. 1993;267(2):744–50.

    CAS  PubMed  Google Scholar 

  4. Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol. 2011;49(4):277–83.

    Article  CAS  Google Scholar 

  5. Perez E, Bania TC, Medlej K, Chu J. Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model. Acad Emerg Med. 2008;15(12):1284–9.

    Article  PubMed  Google Scholar 

  6. Bania TC, Chu J, Perez E, Su M, Hahn IH. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med. 2007;14(2):105–11.

    Article  PubMed  Google Scholar 

  7. Tebbutt S, Harvey M, Nicholson T, Cave G. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med. 2006;13(2):134–9.

    Article  PubMed  Google Scholar 

  8. Bates N, Chatterton J, Robbins C, Wells K, Hughes J, Stone M, et al. Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec. 2013;172(13):339.

    Article  CAS  PubMed  Google Scholar 

  9. French D, Armenian P, Ruan W, Wong A, Drasner K, Olson KR, et al. Serum verapamil concentrations before and after Intralipid(Registered Trademark) therapy during treatment of an overdose. Clin Toxicol. 2011;49(4):340–4.

    Article  CAS  Google Scholar 

  10. Young AC, Velez LI, Kleinschmidt KC. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose. Resuscitation. 2009;80(5):591–3.

    Article  CAS  PubMed  Google Scholar 

  11. Doepker B, Healy W, Cortez E, Adkins EJ. High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and beta-blocker overdose: a case series. J Emerg Med. 2014;46(4):486–90.

    Article  PubMed  Google Scholar 

  12. Cole JB, Stellpflug SJ, Engebretsen KM. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3):307–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Levine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Ann Emerg Med. 2013;62(3):252–8.

    Article  PubMed  Google Scholar 

  14. Gosselin S, Morris M, Miller-Nesbitt A, Hoffman RS, Hayes BD, Turgeon AF, et al. Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2015;53(6):557–64.

    Article  CAS  Google Scholar 

  15. Kryshtal D, Dawling S, Seger D, Knollmann BC. Intralipid as Novel Antidote for Verapamil Poisoning. Circulation. 2010;122(21).

  16. Knollmann BC, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K, et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006;116(9):2510–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Schlotzer E, Kanning U. Elimination and tolerance of a new parenteral lipid emulsion (SMOF)—a double-blind cross-over study in healthy male volunteers. Ann Nutr Metab. 2004;48(4):263–8.

    Article  CAS  PubMed  Google Scholar 

  18. Nabauer M, Callewaert G, Cleemann L, Morad M. Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science. 1989;244(4906):800–3.

    Article  CAS  PubMed  Google Scholar 

  19. St-Onge M, Dube PA, Gosselin S, Guimont C, Godwin J, Archambault PM, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol. 2014;52(9):926–44.

    Article  CAS  Google Scholar 

  20. Weinberg GL. Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Anesthesiology. 2012;117(1):180–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Fettiplace MR, Akpa BS, Ripper R, Zider B, Lang J, Rubinstein I, et al. Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect. Anesthesiology. 2014;120(4):915–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kuo I, Akpa BS. Validity of the lipid sink as a mechanism for the reversal of local anesthetic systemic toxicity: a physiologically based pharmacokinetic model study. Anesthesiology. 2013;118(6):1350–61.

    Article  CAS  PubMed  Google Scholar 

  23. Partownavid P, Umar S, Li J, Rahman S, Eghbali M. Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats. Crit Care Med. 2012;40(8):2431–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89(14):6452–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51(4):412–5. 5 e1.

    Article  PubMed  Google Scholar 

  26. Clark LA, Beyer J, Graudins A. An in vitro analysis of the effects of intravenous lipid emulsion on free and total local anaesthetic concentrations in human blood and plasma. Crit Care Res Pract. 2014;2014:236520.

    PubMed  PubMed Central  Google Scholar 

  27. Perichon D, Turfus S, Gerostamoulos D, Graudins A. An assessment of the in vivo effects of intravenous lipid emulsion on blood drug concentration and haemodynamics following oro-gastric amitriptyline overdose. Clin Toxicol. 2013;51(4):208–15.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The work was supported in part by American Heart Association grants (post-doctoral fellowship grant to D.O.K. and established investigator grant to B.C.K.)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bjorn C. Knollmann.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 43 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kryshtal, D.O., Dawling, S., Seger, D. et al. In Vitro Studies Indicate Intravenous Lipid Emulsion Acts as Lipid Sink in Verapamil Poisoning. J. Med. Toxicol. 12, 165–171 (2016). https://doi.org/10.1007/s13181-015-0511-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-015-0511-y

Keywords

Navigation